February 17, 2023
Infectious disease specialists in Pennsylvania and around the nation are monitoring the potential rise of Candida auris (C. auris) and other fungal infections.
C. auris—first identified in 2009—has been identified as an emerging fungus that’s a global health threat of unknown origins. While rare, the fungus can cause serious invasive infections in patients that are hard to treat with currently available antifungal medicines.
Pennsylvania recorded a few dozen cases during 2022, according to the most recently available data from the CDC. Nevada recorded the most clinical cases (384) last year.
Here’s what you need to know:
Research is ongoing to understand the origins of C. auris, as well as why it is resistant to antifungal medicines.
HAP continues to support Pennsylvania hospitals as they focus on infection prevention and antimicrobial stewardship. Additional information about C. auris is available online.
For additional information or questions, contact Mary T. Catanzaro, RN, BSMT (ASCP), CIC, FAPIC, project manager, infection prevention, or Lauren Geary, BS, RRT-NPS, CIC, project manager, infection prevention.
Tags: Quality Initiatives | Public Health
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.